NUT carcinoma is driven by NUTM1 gene rearrangements [43], and NUT protein immunohistochemistry (Fig. 5D) is useful to highlight this genetic aberrancy—as NUT protein expression is not normally seen in cells outside of the testis and ciliary ganglion [44]. Here, NUTM1 is linked to nut midline carcinoma.